MATTHEW MORGAN: Open Payments
NPI 1477068351 · JACKSON, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$865 in 42 payments from 19 companies in 2025. Trend: 2023 $978 · 2024 $892 · 2025 $865
Food & beverage: $865
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 7 | $120 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $95 |
| SCPHARMACEUTICALS INC. | 3 | $91 |
| PFIZER INC. | 3 | $69 |
| Novo Nordisk Inc | 2 | $64 |
| Medtronic, Inc. | 3 | $58 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $45 |
| ABIOMED | 2 | $43 |
| Abbott Laboratories | 2 | $35 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $33 |
Products named: LEQVIO, Kerendia, ELIQUIS, FUROSCIX, Wegovy, LifeVest, CARDIOMEMS, JARDIANCE.
Industry payments across MI — which companies pay providers there.
